Related Experiment Video

Updated: Aug 7, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Update on the treatment and prevention of ischaemic stroke

Mark J Alberts1

  • 1Department of Neurology, Northwestern University Medical School, Chicago, Illinois, USA.

Current Medical Research and Opinion
|September 19, 2003
PubMed

Insights

Stroke is increasingly common, with hypertension as a key risk factor. Current treatments like tissue plasminogen activator (tPA) have limitations, prompting research into new stroke prevention therapies.

Area of Science:

  • Neurology
  • Public Health
  • Cardiovascular Medicine

Background:

  • Stroke poses a significant public health challenge, with rising incidence linked to an aging population and improved cardiac patient survival.
  • Hypertension is identified as the primary modifiable risk factor for stroke.
  • Limited therapeutic options exist for acute ischemic stroke, with intravenous tissue plasminogen activator (tPA) being the sole approved treatment, albeit with a notable risk of hemorrhage.

Purpose of the Study:

  • To review the current landscape of stroke epidemiology, risk factors, and treatment options.
  • To highlight the limitations of existing acute stroke therapies.
  • To discuss emerging pharmacological interventions for stroke prevention.

Main Methods:

  • Review of recent epidemiological studies on stroke incidence and risk factors.
  • Analysis of the efficacy and safety profile of intravenous tissue plasminogen activator (tPA).
  • Survey of novel pharmacological agents under investigation for stroke prevention, including statins, estrogen, ACE inhibitors, and ARBs.

Main Results:

  • Stroke incidence is increasing, particularly in older populations.
  • Intravenous tissue plasminogen activator (tPA) is effective for acute ischemic stroke but carries a ~6% risk of symptomatic hemorrhage.
  • Several new drug classes, including statins, ACE inhibitors, and ARBs, are being explored for stroke prevention.

Conclusions:

  • Effective stroke management requires a thorough understanding of individual patient risk factors and underlying stroke mechanisms.
  • The development of novel stroke prevention strategies is crucial to mitigate the growing public health burden of stroke.
  • Personalized medicine approaches are needed to optimize intervention selection for stroke prevention and treatment.

More Related Videos

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...